Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 29 studies | 48% ± 16% | |
| pericyte | 23 studies | 33% ± 17% | |
| myofibroblast cell | 11 studies | 32% ± 10% | |
| fibroblast | 6 studies | 21% ± 5% | |
| retinal cone cell | 6 studies | 48% ± 13% | |
| retinal rod cell | 5 studies | 30% ± 3% | |
| myoepithelial cell | 4 studies | 38% ± 22% | |
| muscle cell | 3 studies | 63% ± 23% | |
| connective tissue cell | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 5 studies | 22% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 82% | 25408.39 | 200 / 245 | 99% | 116.39 | 497 / 502 |
| breast | 77% | 10811.12 | 355 / 459 | 82% | 17.02 | 921 / 1118 |
| bladder | 95% | 54930.71 | 20 / 21 | 59% | 22.95 | 295 / 504 |
| intestine | 78% | 46571.60 | 756 / 966 | 67% | 19.07 | 353 / 527 |
| uterus | 98% | 41343.69 | 166 / 170 | 42% | 48.16 | 193 / 459 |
| esophagus | 75% | 60147.08 | 1084 / 1445 | 60% | 29.32 | 109 / 183 |
| stomach | 50% | 29281.92 | 178 / 359 | 71% | 39.19 | 202 / 286 |
| adrenal gland | 43% | 5410.95 | 112 / 258 | 58% | 15.08 | 133 / 230 |
| blood vessel | 100% | 103148.50 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 27% | 3354.46 | 179 / 653 | 72% | 16.13 | 435 / 605 |
| lung | 32% | 3660.08 | 183 / 578 | 66% | 18.69 | 764 / 1155 |
| ovary | 48% | 8359.55 | 86 / 180 | 43% | 5.73 | 186 / 430 |
| pancreas | 0% | 0 | 0 / 328 | 90% | 33.25 | 161 / 178 |
| brain | 1% | 89.44 | 16 / 2642 | 85% | 13.32 | 602 / 705 |
| adipose | 73% | 16777.36 | 883 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 3% | 437.10 | 3 / 89 | 58% | 13.22 | 526 / 901 |
| liver | 0% | 0 | 0 / 226 | 31% | 6.10 | 127 / 406 |
| skin | 13% | 1657.89 | 232 / 1809 | 15% | 1.69 | 73 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 1.43 | 9 / 45 |
| muscle | 11% | 1246.36 | 90 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.79 | 5 / 80 |
| spleen | 5% | 547.51 | 12 / 241 | 0% | 0 | 0 / 0 |
| heart | 4% | 374.67 | 31 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007015 | Biological process | actin filament organization |
| GO_0051694 | Biological process | pointed-end actin filament capping |
| GO_0030838 | Biological process | positive regulation of actin filament polymerization |
| GO_0006936 | Biological process | muscle contraction |
| GO_0045010 | Biological process | actin nucleation |
| GO_0030239 | Biological process | myofibril assembly |
| GO_0030016 | Cellular component | myofibril |
| GO_0030017 | Cellular component | sarcomere |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005829 | Cellular component | cytosol |
| GO_0005865 | Cellular component | striated muscle thin filament |
| GO_0016020 | Cellular component | membrane |
| GO_0005884 | Cellular component | actin filament |
| GO_0005523 | Molecular function | tropomyosin binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | LMOD1 |
| Protein name | Leiomodin-1 (64 kDa autoantigen 1D) (64 kDa autoantigen 1D3) (64 kDa autoantigen D1) (Leiomodin, muscle form) (Smooth muscle leiomodin) (SM-Lmod) (Thyroid-associated ophthalmopathy autoantigen) |
| Synonyms | |
| Description | FUNCTION: Required for proper contractility of visceral smooth muscle cells . Mediates nucleation of actin filaments. . |
| Accessions | ENST00000367288.5 [P29536-1] P29536 |
